Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 10/20 | 0.44 |
| ▸ | HTR1A | P08908 | 8/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 8/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 7/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18978964 | 0.80 | ADRA1A (0.48) | ADRA1AHTR1AADRA1BADRA1DGAA | |
| SCHEMBL18978977 | 0.80 | ADRA1A (0.44) | ADRA1AHTR1AADRA1BADRA1DGAA | |
| SCHEMBL14039677 | 0.79 | GRIN1 (0.45) | ADRA1AHTR1AADRA1BADRA1DGAA | |
| SCHEMBL29822277 | 0.75 | GRIN1 (0.49) | ADRA1AHTR1AADRA1BADRA1DGAA | |
| SCHEMBL18978978 | 0.74 | ADRA1A (0.44) | ADRA1AHTR1AADRA1BADRA1D | |
| SCHEMBL28136806 | 0.73 | ADRA1A (0.43) | ADRA1AHTR1AADRA1BADRA1DGAA | |
| SCHEMBL11490512 | 0.73 | NPSR1 (0.37) | ADRA1AHTR1AADRA1BADRA1D | |
| SCHEMBL18978749 | 0.73 | ADRA1A (0.44) | ADRA1AHTR1AADRA1BADRA1D | |
| SCHEMBL10501603 | 0.72 | GRIN1 (0.46) | ADRA1AHTR1AADRA1BADRA1DGAA | |
| SCHEMBL28087950 | 0.72 | SLC6A4 (0.40) | HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11168101-B2 | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same | OTSUKA CHEMICAL CO., LTD. (JP) | 2021-11-09 | — | — | US | disclosed |
| EP-3483169-B1 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | OTSUKA CHEMICAL CO LTD (JP) | 2021-05-26 | — | — | EP | disclosed |
| US-10941169-B2 | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same | OTSUKA CHEMICAL CO., LTD. (JP) | 2021-03-09 | — | — | US | disclosed |
| US-10774100-B2 | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same | OTSUKA CHECMIAL CO., LTD. (JP) | 2020-09-15 | — | — | US | disclosed |
| US-20200277318-A1 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | OTSUKA CHEMICAL CO., LTD. (JP) | 2020-09-03 | — | — | US | disclosed |
| US-20200277317-A1 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | OTSUKA CHEMICAL CO., LTD. (JP) | 2020-09-03 | — | — | US | disclosed |
| US-20190330251-A1 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | OTSUKA CHEMICAL CO., LTD. (JP) | 2019-10-31 | — | — | US | disclosed |
| EP-3492479-A2 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | Otsuka Chemical Co., Ltd. (JP) | 2019-06-05 | — | — | EP | disclosed |
| EP-3483169-A1 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | Otsuka Chemical Co., Ltd. (JP) | 2019-05-15 | — | — | EP | disclosed |
| US-9908909-B2 | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same | OTSUKA CHEMICAL CO., LTD. (JP) | 2018-03-06 | — | — | US | disclosed |
| US-20170233421-A1 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | OTSUKA CHEMICAL CO., LTD. (JP) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11168101-B2 | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same | PPM1A, PPP1CA, PPM1G | ADRA1A 1037/4885HTR1A 2346/4885ADRA1B 2667/4885 |
| US-10774100-B2 | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same | PPM1A, PPM1G, PPP1CA | ADRA1A 1225/4885HTR1A 1982/4885ADRA1B 2554/4885 |
| US-20170233421-A1 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | PPM1A, PPP1CA, PPM1G | ADRA1A 931/4885HTR1A 2304/4885ADRA1B 2407/4885 |
| US-20200277317-A1 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | PPM1A, PPP1CA, PPM1G | ADRA1A 1037/4885HTR1A 2346/4885ADRA1B 2667/4885 |
| US-20200277318-A1 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | PPM1A, PPP1CA, PPM1G | ADRA1A 1099/4885HTR1A 2282/4885ADRA1B 2665/4885 |
| US-20190330251-A1 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | PPM1A, PPM1G, PPP1CA | ADRA1A 1225/4885HTR1A 1982/4885ADRA1B 2554/4885 |
| US-10941169-B2 | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same | PPM1A, PPP1CA, PPM1G | ADRA1A 1099/4885HTR1A 2282/4885ADRA1B 2665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.